Genentech’s plan to limit the availability of cancer drug Avastin, which would require physicians to use a more expensive version of the drug called Lucentis.
Archive for November 29th, 2007
Senator Criticizes Limits On Sales Of Genentech’s Avastin
Thursday, November 29th, 2007Examining Social, Economic Impact Of HIV In Pacific
Thursday, November 29th, 2007Examining the social and economic impact of HIV/AIDS in Pacific countries could help improve the lives of those affected by the disease in the region.
AHIC Recommends E-Prescribing Mandate For Medicare
Thursday, November 29th, 2007HHS Secretary Mike Leavitt seek authority from Congress to mandate electronic prescribing in Medicare.
Republican Debate Includes No Questions On Health Care
Thursday, November 29th, 2007Eight Republican presidential candidates participated in a debate that passed without any questions about health care.
Benefits Of Electronic Health Records Outweigh Risks
Thursday, November 29th, 2007Sixty percent of adults believe the benefits of using electronic health records outweigh the potential privacy risks.
Chinese-American, Black Women With Certain Diets Have Higher Risk For Developing Type 2 Diabetes, Studies Find
Thursday, November 29th, 2007Chinese-American and black women who regularly consume foods with a high glycemic index, such as white bread, potatoes and noodles, have a higher risk of developing type 2 diabetes, according to two separate studies published in the Archives of Internal Medicine on Monday, Reuters Health reports. [click link for full article]
Isolagen Modifies Ongoing Clinical Program For Acne Scars
Thursday, November 29th, 2007FDA has provided follow-up on the Phase III program investigating Isolagen’s Therapy for the treatment of moderate to severe acne scars.
FDA to Hold Hearing on Regulating Salt Content in Food
Thursday, November 29th, 2007FDA will hold hearings on dietary salt consumption in American’s diet. How to limit the salt content in processed foods.
Single Treatment SoloVir ETS Significantly Stops Progression Of Cold Sore Episode
Thursday, November 29th, 2007A study was designed to determine the optimum treatment protocol based upon the immediate delivery of a large bolus of acyclovir into the skin during a herpetic episode.
Indevus Reports Positive Results Of Phase II Octreotide Implant Trial
Thursday, November 29th, 2007Indevus Pharmaceuticals announced positive results from its Phase II octreotide implant trial in patients with acromegaly, a disorder characterized by excessive blood levels of growth hormone and insulin- like growth factor 1.